News Related to Bacterial Infection

Related coverage linked through entity extraction aliases.

Alphyn Biologics Doses First Patients in Phase 2 Trial for Molluscum Contagiosum Treatment

Feb 18, 2026

Alphyn Biologics has dosed the first patients in a Phase 2 trial of Zabalafin Hydrogel for Molluscum Contagiosum, enrolling 54 patients ages 6 months and older in a placebo-controlled study targeting 75% lesion elimination.

FDA Approves Zycubo for Menkes Disease After Manufacturing Issue Resolution

Oct 01, 2025

The FDA approved Zycubo (copper histidinate) on January 13, 2026, as the first treatment for Menkes disease in pediatric patients, following resolution of manufacturing compliance concerns that led to an initial rejection in September 2025.